|
Volumn 17, Issue 12, 2007, Pages 3504-3507
|
3,4-Dihydro-2H-benzo[1,4]oxazine derivatives as 5-HT6 receptor antagonists
|
Author keywords
5 HT6 antagonist; Benzoxazine; Brain penetration; hERG; Lipophilicity
|
Indexed keywords
3,4 DIHYDRO 2H BENZO[1,4]OXAZINE DERIVATIVE;
5 CHLORO N [4 METHOXY 3 (1 PIPERAZINYL)PHENYL] 3 METHYL 2 BENZOTHIOPHENESULFONAMIDE;
POTASSIUM CHANNEL HERG;
R 1485;
RO 65 7674;
SEROTONIN 6 ANTAGONIST;
UNCLASSIFIED DRUG;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL TISSUE;
ARTICLE;
CONTROLLED STUDY;
DRUG BRAIN LEVEL;
DRUG DESIGN;
DRUG PENETRATION;
DRUG RECEPTOR BINDING;
DRUG SYNTHESIS;
IC 50;
INHIBITION KINETICS;
LIPOPHILICITY;
NONHUMAN;
RAT;
RECEPTOR AFFINITY;
RECEPTOR BLOCKING;
SEROTONIN RELEASE;
SINGLE DRUG DOSE;
ANIMALS;
MODELS, CHEMICAL;
OXAZINES;
RATS;
RECEPTORS, SEROTONIN;
SEROTONIN ANTAGONISTS;
STRUCTURE-ACTIVITY RELATIONSHIP;
RATTUS;
|
EID: 34249739164
PISSN: 0960894X
EISSN: None
Source Type: Journal
DOI: 10.1016/j.bmcl.2006.12.093 Document Type: Article |
Times cited : (39)
|
References (13)
|